Join our emailing list to become a part of our community and receive periodic communications about grant funding opportunities, as well as news and updates.
- MD or PhD (or equivalent)
- Faculty position at an accredited academic medical center, university or research institution in the US, Canada or the UK, and conduct the majority of his/her/their research at that institution
- Proposals should support the development of a therapeutic that could treat, prevent, or slow Alzheimer’s disease or related dementias
- A project must have only a single Principal Investigator (PI), who is responsible for project oversight and financial management. The PI may engage collaborators, core labs or commercial CROs to execute any portion of the project.
- Past recipients of Harrington awards may submit new and distinct proposals, but may not seek additional support for previously funded projects.
Late submissions will not be accepted for any reason, other than issues with the Harrington Discovery Institute’s submission system. Proposals received after the deadline will not be reviewed.
The ADDF-Harrington Scholar award selection committee seeks breakthrough discoveries that demonstrate innovation, creativity and potential for clinical impact, including:
- Discoveries deemed to address unmet medical needs
- Modulators of novel targets
- Potential to be developed into a commercial program
- Strong intellectual property (IP) or protection strategy
- May be either a small molecule, biologic, or other therapeutic modality
- Diagnostics or devices only acceptable as part of a therapeutic development project
The 2022 ADDF-Harrington Scholars will be notified in May 2023.
Below is the timeline for the 2023 ADDF-Harrington program.
- Call Opens for Letters of Intent (LOI)
April 3, 2023
- LOI Submission Deadline
May 29, 2023
- Full Application Deadline for those Invited
September 11, 2023
- Announce 2023 ADDF-Harrington Scholars
HOW TO APPLY APPLY NOW